Cited by 796Substance Abuse Treatment and OutcomesMental Health Treatment and AccessSmoking Behavior and Cessation

Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO world mental health surveys

Open access
Degenhardt, Louisa, Chiu, Wai-Tat, Sampson, Nancy, Kessler, Ronald C, Anthony, James C, Angermeyer, Matthias, Bruffaerts, Ronny, de Girolamo, Giovanni +13 more·2008·PLoS Medicine

Abstract

BACKGROUND: Alcohol, tobacco, and illegal drug use cause considerable morbidity and mortality, but good cross-national epidemiological data are limited. This paper describes such data from the first 17 countries participating in the World Health Organization's (WHO's) World Mental Health (WMH) Survey Initiative. METHODS AND FINDINGS: Household surveys with a combined sample size of 85,052 were carried out in the Americas (Colombia, Mexico, United States), Europe (Belgium, France, Germany, Italy, Netherlands, Spain, Ukraine), Middle East and Africa (Israel, Lebanon, Nigeria, South Africa), Asia (Japan, People's Republic of China), and Oceania (New Zealand). The WHO Composite International Diagnostic Interview (CIDI) was used to assess the prevalence and correlates of a wide variety of mental and substance disorders. This paper focuses on lifetime use and age of initiation of tobacco, alcohol, cannabis, and cocaine. Alcohol had been used by most in the Americas, Europe, Japan, and New Zealand, with smaller proportions in the Middle East, Africa, and China. Cannabis use in the US and New Zealand (both 42%) was far higher than in any other country. The US was also an outlier in cocaine use (16%). Males were more likely than females to have used drugs; and a sex-cohort interaction was observed, whereby not only were younger cohorts more likely to use all drugs, but the male-female gap was closing in more recent cohorts. The period of risk for drug initiation also appears to be lengthening longer into adulthood among more recent cohorts. Associations with sociodemographic variables were consistent across countries, as were the curves of incidence of lifetime use. CONCLUSIONS: Globally, drug use is not distributed evenly and is not simply related to drug policy, since countries with stringent user-level illegal drug policies did not have lower levels of use than countries with liberal ones. Sex differences were consistently documented, but are decreasing in more recent cohorts, who also have higher levels of illegal drug use and extensions in the period of risk for initiation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.0050141

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Research Triangle Institute 2002 SUDAAN Version 8.0.1. 7.5.3 edition Research Triangle Park (North Carolina) Research Triangle Institute
  2. Research Triangle Institute 2002 SUDAAN: Professional Software for Survey Data Analysis. 8.01 edition Research Triangle Park (North Carolina) Research Triangle Institute

Cited by

Sorted by citations

Authors
Degenhardt, L., Chiu, W.-T., Sampson, N., Kessler, R. C., Anthony, J. C., Angermeyer, M., Bruffaerts, R., de Girolamo, G., Gureje, O., Huang, Y., Karam, A., Kostyuchenko, S., Lepine, J. P., Mora, M. E. M., Neumark, Y., Ormel, J. H., Pinto-Meza, A., Posada-Villa, J., Stein, D. J., Takeshima, T., & Wells, J. E.
Affiliations
  • UNSW Sydney (AU)
  • Harvard University (US)
  • Michigan State University (US)
  • Leipzig University (DE)
  • Universitair Ziekenhuis Leuven (BE)
  • University College Hospital, Ibadan (NG)
  • Peking University (CN)
  • Hôpital Fernand-Widal (FR)
  • Hebrew University of Jerusalem (IL)
  • University Medical Center Groningen (NL)
  • University of Cape Town (ZA)
  • National Center of Neurology and Psychiatry (JP)
Corresponding author
Degenhardt, Louisa
Venue
PLoS Medicine
Published
2008-07-01
Volume
5
Issue
7
Pages
e141
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2107259975
Cited by
796
References
55
Citations by year
2026: 15 · 2025: 17 · 2024: 19 · 2023: 21 · 2022: 28 · 2021: 46 · 2020: 39 · 2019: 39 · 2018: 54 · 2017: 62 · 2016: 61 · 2015: 53 · 2014: 72 · 2013: 59 · 2012: 68
FWCI
35.49
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Open University of Cape Town (University of Cape Town) (submittedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Open University of Cape Town (University of Cape Town) (submittedVersion, cc-by)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
  • Greater South Information System
Funders
  • Robert Wood Johnson Foundation (044708, Grant 044708)
  • John W. Alden Trust (R01-MH069864, R13-MH066849)
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • World Health Organization
  • University of Michigan
  • Australian Government
  • European Commission (1999-01042, QLG5–1999-01042, SANCO2004123, 2004123)
  • Generalitat de Catalunya (01042, CB06/02/0046)
  • Bundesministerium für Gesundheit
  • National Insurance Institute of Israel (H13-SHOGAI-023, H16-KOKORO-013, H14-TOKUBETSU-026)
  • Ministry of Health, Labour and Welfare (H16-KOKORO-013, H14-TOKUBETSU-026, H13-SHOGAI-023)
  • Regione Piemonte (00/0028)
  • National Institutes of Health (5r13mh066849-04, 5r01mh069864-04, 5r01mh070884-05)
  • Substance Abuse and Mental Health Services Administration (044708)
  • Pfizer Foundation (R01‐MH069864, R01-DA016558, R13-MH066849)
  • Pan American Health Organization
  • Medical Research Council
  • National Health and Medical Research Council
  • Instituto de Salud Carlos III (CB06/02/0046, FIS 00/0028, CIBER CB06/02/0046)
  • Departament de Salut, Generalitat de Catalunya (CB06/02/0046)
  • National Institute of Mental Health (R13-MH-066849, RO1-MH61905, R0 1-MH61905, R01‐MH070884, MH61905, U01-MH-60220, R01MH061905, R01MH059575, MH60220, MH069864, MH066849, U01MH060220, R01‐MH069864)
  • National Institute on Drug Abuse (K05DA015799, R01DA016558, U01-MH60220)
  • Fogarty International Center (FIRCA R01-TW006481, R01-TW006481, R03TW006481)
  • Cilag
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
Keywords
alcohol consumption, tobacco use, cannabis use, cocaine use, substance use prevalence, sex differences in drug use, cross-national comparison, lifetime substance use
MeSH terms
Adolescent, Adult, Cannabis, Marijuana Abuse, Female, Health Surveys, Humans, Male, Mental Health, Tobacco Use Disorder, Global Health, World Health Organization, Cohort Studies, Cocaine-Related Disorders, Alcohol-Related Disorders, Internationality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review